Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition

    Published: March 20, 2018 | Price: $4,500.00 – $9,000.00

    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition In eight editions, Kalorama Information's report, Outsourcing in Drug Discovery, has kept the industry informed, providing answers to these questions and more. The 8th edition contains 2017 market size estimates and 2022 forecasts for 21 different parts of the process that might be outsourced, including: Chemistry Services Market, 2017-2022 Building Blocks Outsourcing Market, 2017-2022 Compound Synthesis Market, 2017-2022 Library Construction Market, 2017-2022 Process Research Market, 2017-2022 Biology Services...
    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, Forecasts to 2018, 6th Edition

    Published: April 30, 2014 | Price: $995.00 – $1,990.00

    For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process. This Kalorama Information Report, Outsourcing in Drug Discovery, t provides an in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for the following segments. Chemistry Services Market: Building Blocks, Compound Synthesis, Libraries,...
    PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)

    Published: April 12, 2017 | Price: $3,196.00 – $6,392.00

    PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes opportunity estimates for both research and diagnostic uses of PCR, by geography, with forecasts to 2021; global analysis of PCR and other NAAT technologies; examination of the applications of PCR and other NAAT in research and...
    PCR Markets for Life Sciences Applications (Market by Type – qPCR, dPCR – Application – Pharmaceutical, General Research, and by Country and Region)

    Published: March 2, 2018 | Price: $3,995.00 – $7,990.00

    PCR Markets for Life Sciences Applications (Market by Type - qPCR, dPCR - Application - Pharmaceutical, General Research, and by Country and Region) As part of its coverage of this market, Kalorama Information's report provides: The Market for Life Sciences PCR, 2017 to 2022 Application Market Segmentation of Pharmaceutical and General Medical Research  Market Segmentation of qPCR and dPCR markets, 2017-2022 United States Life Sciences PCR Market, 2017-2022 European Life Sciences PCR Market, 2017-2022 Japanese Market for Life Sciences PCR,...
    Pediatric Drugs: the Worldwide Market, 3rd Edition

    Published: January 1, 2008 | Price: $995.00 – $7,990.00

    Although much of medicine is focused on the increased aging of the population, children still represent the bulk the dependent population worldwide. Important regulatory factors are at work in the pediatric pharmaceutical market. The recognition of the rights of children to have access to safe and effective drugs and the needs of healthcare providers to have access to age-appropriate drug information continues to have a major effect on all areas of pediatric pharmaceuticals including pediatric biomedical research. Pediatric Drugs, the...
    Pharmaceutical Excipients for Oral Formulations, 2nd. Edition

    Published: February 1, 2008 | Price: $995.00 – $7,990.00

    Pharmaceutical excipients are substances, other than the pharmacologically active drug or prodrug, which are included in the manufacturing process or are contained in the finished pharmaceutical product dosage form. Excipients provide enhanced functionality to the pharmaceuticals, aid the innovations in the drug development and help improve patent life as well. Excipients make the products more functional at a lower cost, a benefit much desired by the pharmaceutical industry that is inundated with pressures to reduce costs. All in all, excipients...
    Pharmaceutical Market Research Bundle (Monoclonal Antibody Markets, CMOs, Bioprocessing Markets, Biosimilar Drug Markets)

    Published: May 30, 2018 | Price: $11,995.00 – $23,990.00

    Kalorama Information Market Research Bundles allow customers to experience savings while obtaining a large amount of research on topics of importance in pharmaceuticals.  This bundle represents essential trends in the pharmaceutical industry currently.  It is combination of 4 complete Kalorama Information reports, including the following: What's Trending in Monoclonal Antibodies Biopharmaceutical Contract Manufacturing Organization Markets Single-Use Upstream Bioprocessing Markets The World Market for BiosimilarsThe reports are separate PDFs, exactly as they were published, combined into one.  A separate Table of...
    Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )

    Published: July 1, 2008 | Price: $500.00 – $7,000.00

    Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich nations will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. Kalorama's Pharmaceutical Markets in Brazil, Russia, India and China (BRIC nations) takes a...
    Pharmaceutical Markets in India

    Published: April 1, 2009 | Price: $995.00 – $2,590.00

    The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This report Pharmaceutical Market in India provides market watchers with needed information on this growing market, including:   Market Size and Forecast...
    Pharmaceutical Markets in Russia

    Published: January 1, 2009 | Price: $995.00 – $1,990.00

    The pharmaceutical market in Russia ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be one of several that major pharmaceutical companies are exploring for new opportunities for growth. Reliance on commodity prices makes Russia's economy and government spending on healthcare variable, but awareness of healthcare issues, especially among the younger population, and a willingness to spend personal funds on healthcare will drive Russian markets. For the...
    Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)

    Published: November 1, 2008 | Price: $995.00 – $1,990.00

    At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This Kalorama Information report, Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends) takes a thorough look at the...
    Pharmaceutical Outsourcing Opportunities Post Launch: Contract Manufacturing, and Sales and Marketing

    Published: July 1, 2004 | Price: $3,500.00 – $7,000.00

    After decades of sustained growth and profitability, the pharmaceutical industry has been positioned as one of the few recession proof industries based on its performance through multiple economical cycles. In recent years, there have been visible strains in the pharmaceutical business. With a downturn in fortunes, many pharmaceutical companies are searching for business solutions to streamline operations and cut costs as they strive to continue generating above-average shareholder returns. Outsourcing has become an integral, ongoing element of pharmaceutical companies’ business...
    Pharmaceutical Outsourcing Opportunities Post-Launch – Contract Manufacturing and Contract Sales and Marketing, 2nd Edition

    Published: September 1, 2006 | Price: $3,900.00 – $7,800.00

    This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. The report contains vital market statistics on three main segments of pharmaceutical contract manufacturing: Biopharmaceutical manufacturing, including monoclonal antibodies (MAbs), complex proteins, peptides, nucleotides, DNA vaccines, and gene therapy. Primary pharmaceutical manufacturing, including non-sterile and sterile active pharmaceutical ingredients (APIs), custom chemicals, certain specialized manufacturing...
    Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition

    Published: January 1, 2009 | Price: $995.00 – $7,000.00

    This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. A major factor driving the upward trend in the number of manufacturing projects being outsourced is that specialized production, i.e., sterile manufacturing, biopharmaceutical manufacturing and specialized processes, such as chiral chemistry and improvements in catalyst activity, is often not included in the...
    Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

    Published: August 3, 2012 | Price: $2,500.00 – $5,000.00

    What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies.  Together, they have the potential to add billions in value to the current pharmaceutical market in the next five years. What types of drugs are companies developing and what will be the impact of these products on the marketplace and key competitors?   In this report, Kalorama Information has analyzed the late-stage R&D pipeline of the...